Pneumococcal infections in high-risk and immunocompromised hosts

Olarn Prommalikit1, Krisana Pengsaa, Usa Thisyakorn

  • 1Department of Pediatrics, Faculty of Medicine, Srinakharinwirot University, Bangkok, Thailand. drolarnp2002@yahoo.com

Insights

Streptococcus pneumoniae causes significant global disease, particularly invasive pneumococcal disease (IPD). Understanding risk factors like immunocompromised status is key to preventing infections in vulnerable populations.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Microbiology

Background:

  • Streptococcus pneumoniae is a major global pathogen causing significant morbidity and mortality.
  • It is responsible for invasive pneumococcal disease (IPD) and non-IPD, with high incidence in young children, the elderly, and immunocompromised individuals.
  • Nasopharyngeal colonization precedes IPD, highlighting the importance of understanding host-pathogen interactions.

Purpose of the Study:

  • To describe the factors contributing to the development of invasive pneumococcal disease.
  • To elucidate the role of host immunity, genetics, and environmental factors in pneumococcal infections.
  • To detail immunocompromising conditions predisposing individuals to pneumococcal disease.

Main Methods:

  • Review of existing literature on Streptococcus pneumoniae epidemiology and pathogenesis.
  • Analysis of host-related factors, including immune status, age, and genetic predispositions.
  • Identification of specific immune defects and conditions associated with increased IPD risk.

Main Results:

  • Invasive pneumococcal disease development is influenced by a combination of host immunity (innate and specific), genetic, and environmental factors.
  • Specific host responses to pneumococcal infections can be compromised by factors such as young age, antibody deficiencies, complement factor deficiencies, and splenic dysfunction.
  • Immunocompromised hosts and individuals with specific underlying medical conditions exhibit higher rates of IPD.

Conclusions:

  • Understanding the complex interplay of host factors is crucial for preventing and managing Streptococcus pneumoniae infections.
  • Identifying and addressing specific immune defects can mitigate the risk of invasive pneumococcal disease.
  • Further research into host-pathogen dynamics in immunocompromised populations is warranted.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: